Plasmodium vivax and the Duffy antigen: A paradigm revisited;Plasmodium vivax et l'antigène Duffy: Un paradigme revisité

Transfusion Clinique et Biologique

Volumn 17, Issue 3, 2010, Pages 176-183

  Mercereau Puijalon, O ^a,b   Menard D ^a,b,c  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

Duffy blood group; Evolution; Malaria; Plasmodium vivax; Receptor

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; BLOOD GROUP ANTIGEN; CHEMOKINE RECEPTOR; DUFFY BINDING PROTEIN;

AFRICA; BLOOD GROUP DUFFY SYSTEM; CELL INVASION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; HUMAN; INFECTION RESISTANCE; INFECTION SENSITIVITY; MALARIA; PARASITE TRANSMISSION; PATHOGENESIS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77955851840     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2010.06.005     Document Type: Short Survey

References (61)

1. Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A., Hadley T.J., et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993, 261:1182-1184.
2. Neote K., Darbonne W., Ogez J., Horuk R., Schall T.J. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993, 268:12247-12249.
3. Cutbush M., Mollinson P.L., Parkin D.M. A new human blood group. Nature 1950, 165:188-190.
4. Chaudhuri A., Polyakova J., Zbrzezna V., Pogo A.O. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995, 85:615-621.
5. Hadley T.J., David P.H., McGinniss M.H., Miller L.H. Identification of an erythrocyte component carrying the Duffy blood group Fy-a antigen. Science 1984, 223:597-599.
6. Peiper S.C., Wang Z.X., Neote K., Martin A.W., Showell H.J., Conklyn M.J., et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995, 181:1311-1317.
7. Rot A., Horuk R. Chapter 9 the duffy antigen receptor for chemokines. Methods Enzymol 2009, 461:191-206.
8. Tournamille C., Le Van Kim C., Gane P., Cartron J.P., Colin Y. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995, 95:407-410.
9. Tournamille C., Colin Y., Cartron J.P., Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995, 10:224-228.
10. Zimmerman P.A., Woolley I., Masinde G.L., Miller S.M., McNamara D.T., Hazlett F., et al. Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A 1999, 96:13973-13977.
11. Kasehagen L.J., Mueller I., Kiniboro B., Bockarie M.J., Reeder J.C., Kazura J.W., et al. Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS One 2007, 2(3):e336.
12. Albuquerque S.R., Cavalcante Fde O., Sanguino E.C., Tezza L., Chacon F., Castilho L., et al. FY polymorphisms and vivax malaria in inhabitants of Amazonas State Brazil. Parasitol Res 2010, 106:1049-1053.
13. Tournamille C., Le Van Kim C., Gane P., Le Pennec P.Y., Roubinet F., Babinet J., et al. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998, 92:2147-2156. Erratum in Blood 2000;95(9):2753.
14. Olsson M.L., Smythe J.S., Hansson C., Poole J., Mallinson G., Jones J., et al. The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 1998, 103:1184-1191.
15. Ménard D., Barnadas C., Bouchier C., Henry-Halldin C., Gray R., Ratsimbasoa A., et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 2010, 107:5967-5971.
16. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol 2007, 23:533-539.
17. Galinski M.R., Barnwell J.W. Plasmodium vivax: who cares?. Malar J 2008, 7(Suppl. 1):S9.
18. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77(6 Suppl.):79-87.
19. Mueller I., Galinski M.R., Baird J.K., Carlton J.M., Kochar D.K., Alonso P.L., et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009, 9:555-566.
20. Baird J.K. Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev 2009, 22:508-534.
21. Karunajeewa H.A., Mueller I., Senn M., Lin E., Law I., Gomorrai P.S., et al. A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med 2008, 359:2545-2557.
22. Oliveira-Ferreira J., Lacerda M.V., Brasil P., Ladislau J.L., Tauil P.L., Daniel-Ribeiro C.T. Malaria in Brazil: an overview. Malar J 2010, 9:115.
23. Guerra C.A., Snow R.W., Hay S.I. Mapping the global extent of malaria in 2005. Trends Parasitol 2006, 22:353-358.
24. Santos-Ciminera P.D., Roberts D.R., Alecrim M., das G.C., Costa M.R.F., Quinnan G.V. Malaria diagnosis and hospitalization trends Brazil. Emerging Infect Dis 2007, 13:1597-1600.
25. Barcus M.J., Basri H., Picarima H., Manyakori C., Sekartuti, Elyazar I., et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007, 77:984-991.
26. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua Indonesia. PLoS Med 2008, 5:e128.
27. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008, 5:e127.
28. Poespoprodjo J.R., Fobia W., Kenangalem E., Lampah D.A., Hasanuddin A., Warikar N., et al. Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis 2009, 48:1704-1712.
29. Anstey N.M., Russell B., Yeo T.W., Price R.N. The pathophysiology of vivax malaria. Trends Parasitol 2009, 25:220-227.
30. Baird J.K. Severe and fatal vivax malaria challenges " benign tertian malaria" dogma. Ann Trop Paediatr 2009, 29:251-252.
31. Mathews H.M., Armstrong J.C. Duffy blood types and vivax malaria in Ethiopia. Am J Trop Med Hyg 1981, 30:299-303.
32. Escudie A., Hamon J. Le paludisme en Afrique occidentale d'expression française. Med Trop 1961, 21(Special):661-687.
33. Zwetyenga J., Rogier C., Tall A., Fontenille D., Snounou G., Trape J.F., et al. No influence of age on infection complexity and allelic distribution in P. falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg 1998, 59:726-735.
34. Mühlberger N., Jelinek T., Gascon J., Probst M., Zoller T., Schunk M., et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 2004, 3:5.
35. Culleton R.L., Mita T., Ndounga M., Unger H., Cravo P.V.L., Paganotti G.M., et al. Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J 2008, 7:174-182.
36. Young M.D., Eyles D.E., Burgess R.W., Jeffery G.M. Experimental testing of the immunity of Negroes to Plasmodium vivax. J Parasitol 1955, 41:315-318.
37. Boyd M.F., Stratman-Thomas W.K. Studies on benign tertian malaria 4. On the refractoriness of Negroes to inoculation with Plasmodium vivax. Am J Hyg 1933, 18:485-489.
38. Young M.D., Ellis J.M., Stubbs T.H. Some Characteristics of Foreign Vivax Malaria Induced in Neurosyphilitic Patients. Am J Trop Med Hyg 1947, s1-27:585-596.
39. Bray R.S. The susceptibility of Liberians to the Madagascar strain of Plasmodium vivax. J Parasitol 1958, 44:371-373.
40. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood group genotype, FyFy. N Engl J Med 1976, 295:302-304.
41. Cox-Singh J., Davis T.M., Lee K.S., Shamsul S.S., Matusop A., Ratnam S., et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008, 46:165-171.
42. Miller L.H., Mason S.J., Dvorak J.A. Erythrocyte receptors of Plasmodium knowlesi malaria: Duffy blood group determinants. Science 1975, 189:561-562.
43. Barnwell J.W., Nichols M.E., Rubinstein P. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 1989, 169:1795-1802.
44. Tournamille C., Blancher A., Le Van Kim C., Gane P., Apoil P.A., Nakamoto W., et al. Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines. Immunogenetics 2004, 55:682-694.
45. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
46. Chitnis C.E., Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol 2008, 24:29-34.
47. Chitnis C.E., Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 1994, 180:497-506.
48. Chitnis C.E., Chaudhuri A., Horuk R., Pogo A.O., Miller L.H. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 1996, 184:1531-1536.
49. Tournamille C., Filipe A., Badaut C., Riottot M.M., Longacre S., Cartron J.P., et al. Fine mapping of the Duffy antigen binding site for the Plasmodium vivax Duffy-binding protein. Mol Biochem Parasitol 2005, 144:100-103.
50. Choe H., Moore M.J., Owens C.M., Wright P.L., Vasilieva N., Li W., et al. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol Microbiol 2005, 55:1413-1422.
51. Grimberg B.T., Udomsangpetch R., Xainli J., McHenry A., Panichakul T., Sattabongkot J., et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 2007, 4:e337.
52. King C.L., Michon P., Shakri A.R., Marcotty A., Stanisic D., Zimmerman P.A., et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 2008, 105:8363-8368.
53. Singh S.K., Hora R., Belrhali H., Chitnis C.E., Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 2006, 439:741-744.
54. Butler F.A., Sapero J.J. Pacific vivax malaria in the American Negro. Am J Trop Med Hyg 1947, 27:111-115.
55. Spencer H.C., Miller L.H., Collins W.E., Knud-Hansen C., McGinnis M.H., Shiroishi T., et al. The Duffy blood group and resistance to Plasmodium vivax in Honduras. Am J Trop Med Hyg 1978, 24:664-670.
56. Ryan J.R., Stoute J.A., Amon J., Dunton R.F., Mtalib R., Koros J., et al. Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in Western Kenya. Am J Trop Med Hyg 2006, 75:575-581.
57. Cavasini C.E., Mattos L.C., Couto A.A., Bonini-Domingos C.R., Valencia S.H., Neiras W.C., et al. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception?. Trans R Soc Trop Med Hyg 2007, 101:1042-1044.
58. Cavasini C.E., de Mattos L.C., Couto A.A., Couto V.S., Gollino Y., Moretti L.J., et al. Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar J 2007, 6:167.
59. Escalante A.A., Cornejo O.E., Freeland D.E., Poe A.C., Durrego E., Collins W.E., et al. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc Natl Acad Sci U S A 2005, 102:1980-1985.
60. Cornejo O.E., Escalante A.A. The origin and age of Plasmodium vivax. Trends Parasitol 2006, 22:558-563.
61. Allen S.J., O'Donnell A., Alexander N.D., Alpers M.P., Peto T.E., Clegg J.B., et al. Alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A 1997, 94:14736-14741.